ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Emergency Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,835Medicare Part D Prescriptions Filled, Including Refills

Rank: 8 out of 720

$548K Total Retail Price of All Prescriptions

Rank: 8 out of 720

304 Patients Receiving at Least One Drug in Part D
56%Patients 65 Years and Older
77% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

17% of this provider’s 304 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

28% of this provider’s 304 patients filled at least one prescription for a schedule three drug, compared to an average of 32%.

Risky Drugs to Seniors

2% of this provider’s 4,189 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 12%.

Prescription Price

$70 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 3.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
HYDROCODONE-ACETAMINOPHEN 580 211 S3 1 1
FUROSEMIDE 282 191 2 8
LEVOTHYROXINE SODIUM 280 184 3 5
OMEPRAZOLE 238 115 4 4
SIMVASTATIN 205 154 5 2
GABAPENTIN 192 89 6 15
LISINOPRIL 190 145 7 3
METFORMIN HCL 188 103 8 7
HYDROCHLOROTHIAZIDE 176 131 9 10
POTASSIUM CHLORIDE 176 108 9 34
METHADONE HCL 129 80 S2 11 130
CITALOPRAM HBR 115 61 12 68
LANTUS 114 33 13 37
AMLODIPINE BESYLATE 111 84 14 6
CARVEDILOL 98 66 15 22
PREDNISONE 96 47 16 43
TRAZODONE HCL 93 40 17 89
ATORVASTATIN CALCIUM 90 67 18 23
OXYCODONE HCL-ACETAMINOPHEN 87 31 S2 19 182
IBUPROFEN 85 52 20 9
TRIAMCINOLONE ACETONIDE 82 67 21 108
NAPROXEN 81 47 22 44
METOPROLOL TARTRATE 77 49 23 13
ADVAIR DISKUS 74 41 24 29
NEXIUM 70 28 25 25
BACLOFEN 68 14 26 63
AMITRIPTYLINE HCL 67 19 R 27 67
ATENOLOL 65 44 28 12
WARFARIN SODIUM 64 35 29 19
OXYCODONE-ACETAMINOPHEN 63 18 S2 30 42
LANTUS SOLOSTAR 58 29 31 151
PROAIR HFA 58 15 31 50
DOXYCYCLINE HYCLATE 58 36 31 92
FLUOXETINE HCL 55 12 34 113
INSULIN SYRINGE 55 0 34 74
ZOLPIDEM TARTRATE 54 35 36 14
TRAMADOL HCL 52 18 37 16
LOVASTATIN 52 39 37 30
QUETIAPINE FUMARATE 51 25 39 147
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 9, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.